|
Real-time Estimate
Cboe BZX
20:43:00 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 19.60 USD | -0.25% |
|
-1.23% | -26.45% |
| 12:20pm | RBC Trims Price Target on ACADIA Pharmaceuticals to $36 From $37, Keeps Outperform Rating | MT |
| 09-29 | Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041 | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACAD | Delayed | |
CBOE
| ACAD | Real-time | |
Mexican S.E.
| ACAD * | End-of-day quote | |
Tradegate
| DR6 | Real-time | |
Boerse Muenchen
| DR6 | Real-time | |
Deutsche Boerse AG
| DR6 | Delayed | |
Börse Stuttgart
| DR6 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 24.83 | 24.83 | 24.84 |
| Spread/Res. | -20.78% | -20.78% | -20.81% |
| Spread/Supp. | +17.29% | +17.29% | +10.82% |
| Support | 16.77 | 16.77 | 17.75 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ACAD Stock
- Charts Acadia Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions

















